InvestorsHub Logo
icon url

NASDAQ2020

10/21/18 8:18 AM

#302167 RE: jour_trader #302166

More speculation.
The science says otherwise.
If anything up the dose $

Life is as Big as you make it !

icon url

WeeZuhl

10/21/18 12:55 PM

#302173 RE: jour_trader #302166

Lol.






IMO, if results were significant, the study would have been halted.








Good one. Lol.






icon url

dr_lowenstein

10/21/18 1:36 PM

#302174 RE: jour_trader #302166

correct, it is good to have someone that understands clinical trials. thanks
icon url

Jimmy Joe

10/22/18 12:12 AM

#302188 RE: jour_trader #302166

Okay, like if one company claims to have a gold standard for a particular
ailment that extends lives 6-8 months versus the patient just capitulating?

Even if results are modest I should think it would be better than the alternative.

And

if results were significant, the study would have been halted.

studies are not just halted if results are significant. Significant at what cost to the patient may be a reason to continue with a particular study as an example.

In this case results may be modest, but if you had Parkinson's and this drug was shown to decrease symptoms and extend your life you would have to ask yourself that question.

Is Isradipine worth the incremental cost?